HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xing-Xing Diao Selected Research

TPN171

6/2022Pharmacokinetics, mass balance, and metabolism of [14C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xing-Xing Diao Research Topics

Disease

2Erectile Dysfunction
06/2022 - 03/2021
1Pulmonary Arterial Hypertension
06/2022
1Acute Coronary Syndrome
09/2021
1Human Influenza (Influenza)
02/2021
1Fever (Fevers)
02/2021
1Common Cold
02/2021
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2021

Drug/Important Bio-Agent (IBA)

2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
06/2022 - 03/2021
2Phosphodiesterase 5 InhibitorsIBA
06/2022 - 03/2021
1TPN171IBA
06/2022
1methyl 2- (2- acetoxy- 6,7- dihydrothieno(3,2- c)pyridin- 5(4H)- yl)- 2- (2- chlorophenyl)acetateIBA
09/2021
1TPN729IBA
03/2021
1phillyrinIBA
02/2021
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2021
1AntioxidantsIBA
01/2021
1LigandsIBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1DiosgeninIBA
01/2021
1SteroidsIBA
01/2021